US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Corium

12.68

0.0000

Volume:- -

Turnover:- -

Market Cap:463.05M

PE:-8.20

High:12.68

Open:12.68

Low:12.68

Close:12.68

52wk High:13.93

52wk Low:7.17

Shares:36.52M

Float Shares:9.23M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.5461

EPS(LYR):-1.6440

ROE:--

ROA:--

PB:18.60

PE(LYR):-7.71

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Corium

Exchange:

NASDAQ

Establishment Date:

- -

Employees:

- -

Office Location:

- -

Website:

http://www.coriumgroup.com

Zip Code:

- -

Phone:

- -

Fax:

- -

Introduction:

Corium International, Inc., a biopharmaceutical company, focuses on the development, manufacture, and commercialization of specialty pharmaceutical products in transdermal and transmucosal delivery systems. It offers Clonidine Transdermal Delivery System (TDS), a treatment for hypertension; Fentanyl TDS, a treatment for the management of chronic pain, including cancer-related pain; and Crest Whitestrips for teeth whitening. The companys products under pipeline comprise Twirla, a combination hormonal contraceptive patch, that has completed Phase III clinical trial to deliver ethinyl estradiol and levonorgestrel hormones; MicroCor hPTH(1-34), a transdermal system that has completed Phase 1 and Phase II a clinical trial for the treatment of severe osteoporosis; and Donepezil and Memantine transdermal systems, which completed Phase I clinical trial for the treatment of Alzheimer's disease. In addition, it develops Aripiprazole TDS for the treatment for psychiatric disorders; Ropinirole TDS that is in preclinical stage for the treatment of Parkinson's disease; MicroCor Zolmitriptan that is in preclinical stage for treatment of migraine; and generic transdermal product for the prevention of nausea and vomiting associated with motion sickness. Corium International, Inc. has collaboration agreements primarily with The Procter & Gamble Company; Teva Pharmaceuticals USA, Inc.; Endo Pharmaceuticals, Inc.; Agile Therapeutics, Inc.; and Aequus Pharmaceuticals, Inc. The company was incorporated in 1995 and is headquartered in Menlo Park, California.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/CORI/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CORI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CORI\",,,,,undefined,":{"symbol":"CORI","market":"US","secType":"STK","nameCN":"Corium","latestPrice":12.68,"timestamp":1557518400000,"preClose":12.68,"halted":3,"volume":0,"delay":0,"changeRate":0,"floatShares":9230000,"shares":36517802,"eps":-1.546149,"marketStatus":"Halted","change":0,"latestTime":"02-20 16:23:52 EST","open":12.68,"high":12.68,"low":12.68,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.546149,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1771635600000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1396497600000,"exchange":"NASDAQ","adjPreClose":12.68,"volumeRatio":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CORI\",,,,,undefined,":{"symbol":"CORI","floatShares":9230000,"roa":"--","roe":"--","lyrEps":-1.644018,"shares":36517802,"dividePrice":0,"high":12.68,"amplitude":0,"preClose":12.68,"low":12.68,"week52Low":7.17,"pbRate":"18.60","week52High":13.93,"institutionHeld":0,"latestPrice":12.68,"eps":-1.546149,"divideRate":0,"volume":0,"delay":0,"ttmEps":-1.546149,"open":12.68,"prevYearClose":12.68},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CORI\",params:#limit:5,,,undefined,":[{"market":"US","date":"2018-08-09","symbol":"CORI","fiscalQuarterEnding":"2018/06","expectedEps":-0.39,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1533787200000,"reportTimeType":"post","actualEps":-0.34},{"market":"US","date":"2018-05-14","symbol":"CORI","fiscalQuarterEnding":"2018/03","expectedEps":-0.41,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1526270400000,"reportTimeType":"post","actualEps":-0.5},{"market":"US","date":"2018-02-08","symbol":"CORI","fiscalQuarterEnding":"2017/12","expectedEps":-0.43,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1518066000000,"reportTimeType":"post","actualEps":-0.37},{"market":"US","date":"2017-11-16","symbol":"CORI","fiscalQuarterEnding":"2017/09","expectedEps":-0.43,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1510808400000,"reportTimeType":"post","actualEps":-0.36},{"market":"US","date":"2017-08-03","symbol":"CORI","fiscalQuarterEnding":"2017/06","expectedEps":-0.3,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1501732800000,"reportTimeType":"post","actualEps":-0.43}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CORI\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CORI\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{},"stockCompanyDetail":{"websiteUrl":"http://www.coriumgroup.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0047},{"period":"1month","weight":0.0102},{"period":"3month","weight":0.0386},{"period":"6month","weight":0.0607},{"period":"1year","weight":0.1167},{"period":"ytd","weight":0.0038}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Corium International, Inc., a biopharmaceutical company, focuses on the development, manufacture, and commercialization of specialty pharmaceutical products in transdermal and transmucosal delivery systems. It offers Clonidine Transdermal Delivery System (TDS), a treatment for hypertension; Fentanyl TDS, a treatment for the management of chronic pain, including cancer-related pain; and Crest Whitestrips for teeth whitening. The companys products under pipeline comprise Twirla, a combination hormonal contraceptive patch, that has completed Phase III clinical trial to deliver ethinyl estradiol and levonorgestrel hormones; MicroCor hPTH(1-34), a transdermal system that has completed Phase 1 and Phase II a clinical trial for the treatment of severe osteoporosis; and Donepezil and Memantine transdermal systems, which completed Phase I clinical trial for the treatment of Alzheimer's disease. In addition, it develops Aripiprazole TDS for the treatment for psychiatric disorders; Ropinirole TDS that is in preclinical stage for the treatment of Parkinson's disease; MicroCor Zolmitriptan that is in preclinical stage for treatment of migraine; and generic transdermal product for the prevention of nausea and vomiting associated with motion sickness. Corium International, Inc. has collaboration agreements primarily with The Procter & Gamble Company; Teva Pharmaceuticals USA, Inc.; Endo Pharmaceuticals, Inc.; Agile Therapeutics, Inc.; and Aequus Pharmaceuticals, Inc. The company was incorporated in 1995 and is headquartered in Menlo Park, California.","exchange":"NASDAQ","name":"Corium","nameEN":"Corium"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"CORI\",market:\"US\",,,undefined,":null}}